The Impact of Tofogliflozin on Physiological and Hormonal Function, Serum Electrolytes, and Cardiac Diastolic Function in Elderly Japanese Patients with Type 2 Diabetes Mellitus.
Tofogliflozin對日本老年2型糖尿病患者的生理和激素功能、血清電解質和心臟舒張功能的影響。
Acta Med Okayama 2022-12-26
Concomitant Use of Sodium-Glucose Cotransporter 2 Inhibitors and Overactive Bladder Drugs and the Risk of Urinary Tract Infection.
鈉葡萄糖共轉運輸體2抑製劑與過度活躍膀胱藥物的聯合使用及尿路感染風險。
Clin Pharmacol Ther 2024-04-22
Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
SGLT2 抑制劑在心衰患者中抑制滲透性利尿時的節水效應。
J Am Coll Cardiol 2024-04-12
Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study.
鈉葡萄糖共同轉運蛋白2抑製劑對心衰患者利尿劑劑量的實證研究。
Front Pharmacol 2024-04-18
Effect of SGLT2-Inhibitors on Polygraphic Parameters in Elderly Patients Affected by Heart Failure, Type 2 Diabetes Mellitus, and Sleep Apnea.
SGLT2抑制劑對心力衰竭、2型糖尿病和睡眠呼吸中止患者的多項測試參數的影響。
Biomedicines 2024-05-25
Effects of Switching From Another Sodium-Glucose Cotransporter 2 Inhibitor to Tofogliflozin on Nocturia in Patients With Type 2 Diabetes.
將「Effects of Switching From Another Sodium-Glucose Cotransporter 2 Inhibitor to Tofogliflozin on Nocturia in Patients With Type 2 Diabetes.」翻譯為「將另一種鈉葡萄糖共同轉運蛋白2抑製劑轉換為托福格洛辛對2型糖尿病患者夜尿的影響。」
Cureus 2024-06-03
Effects of 6-month administration of tofogliflozin on cardiac function in elderly patients with heart failure with preserved ejection fraction: A retrospective study of a patient cohort.
托福格列淨對於心臟功能的六個月施用效果:針對老年心臟衰竭且射血分數保留的患者群體的回顧性研究。
Medicine (Baltimore) 2024-08-09
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice.
日本2型糖尿病患者中tofogliflozin的安全性和有效性:一項在常規臨床實踐中的多中心前瞻性觀察研究。
J Diabetes Investig 2024-08-14